Pharmacogenomics and functional gastrointestinal disorders-Reference-Cited by-同舟云学术

Pharmacogenomics and functional gastrointestinal disorders

Published:2005-07 Issue:5 Volume:6 Page:491-501
ISSN:1462-2416
Container-title:Pharmacogenomics
language:en
Short-container-title:Pharmacogenomics

Author:

Camilleri Michael¹

Affiliation:

1. Mayo Clinic College of Medicine, Clinical Enteric Neuroscience Translational and Epidemiological Research Program, Gastroenterology Research Unit, Charlton 8–110200 First Street S.W., Rochester, MN 55905, USA

Abstract

Functional gastrointestinal disorders, including irritable bowel syndrome and functional dyspepsia, are highly prevalent disorders affecting approximately one in four people in Western societies. This article reviews examples of the role of pharmacogenomics in the safety and efficacy of medications used in the management of such disorders. These include variations in the effects of medications metabolized by cytochrome P450 enzymes (e.g., 2D6 and 2C19), and the effects of genetic polymorphisms in the promoter of the serotonin transporter protein, which influence the response to alosetron in patients with diarrhea-predominant irritable bowel syndrome. These observations suggest that pharmacogenomics will introduce a new era in pharmacotherapeutics in gastroenterology.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Genetics,Molecular Medicine

Link

https://www.futuremedicine.com/doi/pdf/10.2217/14622416.6.5.491

Reference73 articles.

1. AGA technical review on irritable bowel syndrome

2. Management of the irritable bowel syndrome

3. Familial Association in Adults With Functional Gastrointestinal Disorders

4. Evidence of a Genetic Contribution to Functional Bowel Disorder

5. Irritable bowel syndrome in twins: Heredity and social learning both contribute to etiology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders of gastric Emptying;Yamada' s Textbook of Gastroenterology;2015-11-27

2. Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders;Pharmacogenomics;2015-04

3. Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study;Alimentary Pharmacology & Therapeutics;2011-07-19

4. Psychological Co-morbidities of Irritable Bowel Syndrome;Psychological Co-morbidities of Physical Illness;2011

5. Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics;Bioorganic & Medicinal Chemistry Letters;2009-07